Haleon (NYSE: HLN) executives acquire shares via company Share Reward Plan

Rhea-AI Filing Summary

Haleon plc reported routine share plan transactions by two senior executives under its Share Reward Plan. On 10 February 2026, General Counsel Adrian Morris acquired 31 ordinary shares at £3.956 as Partnership Shares and received 31 Matching Shares at no cost, for an aggregated volume of 62 shares. On the same date, President, Europe Jonathan Workman acquired 32 Partnership Shares at £3.956 and received 32 Matching Shares at no cost, an aggregated 64 shares. All transactions involved ordinary shares of £0.01 each, traded on the London Stock Exchange.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of February 2026

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	12 February 2026 - “Director/PDMR Shareholding”

99.1

​Haleon plc: Director/PDMR Shareholding

​

12 February 2026: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs").

On 11 February 2026, the Company received notification of the following transactions as detailed below.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Adrian Morris
2	Reason for the notification
a)	Position/status	General Counsel - PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	GB00BMX86B70
	b)	Nature of the transaction	Acquisition of Partnership Shares and award of Matching Shares under the Company's Share Reward Plan
	c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£3.956	31
			£Nil	31 (Matching Shares)
d)		Aggregated information
	- Aggregated volume	62
	- Price
	e)	Date of the transaction	10 February 2026
	f)	Place of the transaction	London Stock Exchange (XLON)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Jonathan Workman
2	Reason for the notification
a)	Position/status	President, Europe - PDMR
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	GB00BMX86B70
	b)	Nature of the transaction	Acquisition of Partnership Shares and award of Matching Shares under the Company's Share Reward Plan
	c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			£3.956	32
			£Nil	32 (Matching Shares)
d)		Aggregated information
	- Aggregated volume	64
	- Price
	e)	Date of the transaction	10 February 2026
	f)	Place of the transaction	London Stock Exchange (XLON)

Amanda Mellor

Company Secretary

About Haleon

Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: February 12, 2026	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

FAQ

What did Haleon plc (HLN) disclose in this 6-K filing?

Haleon plc disclosed routine share transactions by two senior executives under its Share Reward Plan. The report details small acquisitions of ordinary shares and associated matching awards, carried out as part of standard employee share incentive arrangements.

Which Haleon (HLN) executives were involved in the reported share transactions?

The filing reports transactions by General Counsel Adrian Morris and President, Europe Jonathan Workman. Both are classified as Persons Discharging Managerial Responsibilities, meaning their trades must be publicly disclosed under the UK Market Abuse Regulation framework.

How many Haleon (HLN) shares did Adrian Morris acquire?

Adrian Morris acquired 31 Haleon ordinary shares as Partnership Shares at £3.956 each and received 31 Matching Shares at no cost, giving an aggregated transaction volume of 62 shares in total on 10 February 2026.

How many Haleon (HLN) shares did Jonathan Workman acquire?

Jonathan Workman acquired 32 Haleon ordinary shares as Partnership Shares at £3.956 each and received 32 Matching Shares at no cost. His aggregated transaction volume was 64 shares, executed on 10 February 2026 on the London Stock Exchange.

What is the nature of the Haleon (HLN) transactions reported?

The transactions are acquisitions of Partnership Shares and awards of Matching Shares under Haleon’s Share Reward Plan. These are part of an employee share incentive scheme, rather than open-market discretionary buying or selling by the executives.

On which market were the Haleon (HLN) share transactions carried out?

All reported transactions were conducted on the London Stock Exchange, identified as XLON. The financial instrument involved was Haleon plc ordinary shares of £0.01 each, with the identification code GB00BMX86B70 disclosed in the filing.